| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/22/2004 | WO2004033461A1 5-SUBSTITUTED 7,9-DIFLUORO-5H-CHROMENO[3,4-f]QUINOLINE COMPOUNDS AS SELECTIVE PROGESTERONE RECEPTOR MODULATORS |
| 04/22/2004 | WO2004033459A1 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO[3,4-f]QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS |
| 04/22/2004 | WO2004033453A1 Substituted c-imidazo[1,2-a]pyridin-3-yl-methylamines |
| 04/22/2004 | WO2004033446A1 Protein tyrosine kinase inhibitors |
| 04/22/2004 | WO2004033433A1 Pyrazolone compounds and thrombopoietin receptor activator |
| 04/22/2004 | WO2004033420A1 2,2-DI-SUBSTITUTED 1α,25-DIHYDROXY-19-NORVITAMIN D DERIVATIVE |
| 04/22/2004 | WO2004033419A1 Sulfonamides having antiangiogenic and anticancer activity |
| 04/22/2004 | WO2004033416A2 Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine |
| 04/22/2004 | WO2004033415A1 Nitroaniline-based alkylating agents and their use as prodrugs |
| 04/22/2004 | WO2004032966A1 Cell growth regulator |
| 04/22/2004 | WO2004032951A1 Immunotherapy in cancer treatment |
| 04/22/2004 | WO2004032948A1 Extract with anti-tumor and anti-poisonous activity |
| 04/22/2004 | WO2004032947A1 Extract with anti-tumor and anti-poisonous activity |
| 04/22/2004 | WO2004032939A1 Combination therapy with gemcitabine and zd6126 |
| 04/22/2004 | WO2004032937A1 Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| 04/22/2004 | WO2004032933A1 Method for treatment of cancer |
| 04/22/2004 | WO2004032931A1 Method for treatment of cancer |
| 04/22/2004 | WO2004032930A1 Method of treatment for cancer |
| 04/22/2004 | WO2004032925A1 Use of imatinib (glivec, sti-571) to inhibit breast cancer resistance protein (bcrp)-mediated resistance to therapeutic agents |
| 04/22/2004 | WO2004032923A1 Epothilone derivatives for the treatment of multiple myeloma |
| 04/22/2004 | WO2004032912A1 Medicine comprising a thiourea for use as depigmenting agent or anti-mutagenic and anti-carcinogenic agent |
| 04/22/2004 | WO2004032911A2 Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor |
| 04/22/2004 | WO2004032879A2 Compounds, compositions, and methods |
| 04/22/2004 | WO2004032840A2 Compounds, compositions, and methods |
| 04/22/2004 | WO2004032822A2 Formulation of oral compositions comprising arsenic trioxide and methods of use thereof |
| 04/22/2004 | WO2004022544A8 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 04/22/2004 | WO2004020430A3 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/22/2004 | WO2004019959A9 Dna repair enzymes |
| 04/22/2004 | WO2004017987A3 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 04/22/2004 | WO2004016597A3 Protein kinase inhibitors and uses thereof |
| 04/22/2004 | WO2004013077A3 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 04/22/2004 | WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 04/22/2004 | WO2004009784A3 Novel inhibitors of kinases |
| 04/22/2004 | WO2004005243A3 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives |
| 04/22/2004 | WO2004003201A3 Antisense modulation of lrh1 expression |
| 04/22/2004 | WO2003105907A3 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 04/22/2004 | WO2003097879A3 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc |
| 04/22/2004 | WO2003087318A9 Truncated 24 kda basic fibroblast growth factor |
| 04/22/2004 | WO2003078403A3 Derives d’aminoindazoles comme inhibiteurs de proteine-kinase |
| 04/22/2004 | WO2003070965A8 The eaat2 promoter and uses thereof |
| 04/22/2004 | WO2003068249A8 Shark cartilage extracts and use thereof for immunomodulation |
| 04/22/2004 | WO2003064625A3 Oligonucleotide compositions with enhanced efficiency |
| 04/22/2004 | WO2003057722A3 Cyclic tetrapeptide compound and use thereof |
| 04/22/2004 | WO2003057214A8 Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands |
| 04/22/2004 | WO2003027248A8 Antibody inhibitors of gdf-8 and uses thereof |
| 04/22/2004 | WO2003026563A9 Conjugated anti-psychotic drugs and uses thereof |
| 04/22/2004 | WO2003022202A9 Compositions and methods for treatment of cancer |
| 04/22/2004 | WO2003020763A9 Soluble t cell receptor |
| 04/22/2004 | WO2003005999A8 Methods of treating cytokine mediated diseases |
| 04/22/2004 | WO2002102846A3 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 04/22/2004 | WO2002100897A3 Brca1/acc alpha molecular complexes, diagnostic and therapeutic applications |
| 04/22/2004 | WO2002098362A3 Use of rank antagonists to treat cancer |
| 04/22/2004 | WO2002094852A8 Taci-immunoglobulin fusion proteins |
| 04/22/2004 | WO2002092782A3 Diagnosis and treatment of malignant neoplasms |
| 04/22/2004 | WO2002074767A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074748A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002064731A9 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/22/2004 | WO2002058624A9 In situ generation allicin for the treatment of cancer and infectious diseases |
| 04/22/2004 | WO2002036578A9 Triazine derivatives as lpaat-b inhibitors and uses thereof |
| 04/22/2004 | WO2001082949A9 Method of reducing side effects of chemotherapy in cancer patients |
| 04/22/2004 | US20040078837 Four human zinc-finger-containing proteins: MDZ3, MDZ4, MDZ7 and MDZ12 |
| 04/22/2004 | US20040077877 Jun n-terminal kinase inhibitors |
| 04/22/2004 | US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer |
| 04/22/2004 | US20040077854 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 04/22/2004 | US20040077851 Receptor selective cannabimimetic aminoalkylindoles |
| 04/22/2004 | US20040077848 Reacting a polysaccharide from fermentation with isopropanol in a highly saline aqueous solution, n-deacetylation followed by n-sulfation, and treating ammonium salt with an o-sulfating agent |
| 04/22/2004 | US20040077837 Microtubule-associated proteins and tubulins |
| 04/22/2004 | US20040077828 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 04/22/2004 | US20040077780 Thermogelling oligopeptide polymers |
| 04/22/2004 | US20040077728 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage |
| 04/22/2004 | US20040077726 Antiproliferative and anticarcinogenic agents; psoriasis |
| 04/22/2004 | US20040077701 Pyrazole derivates for treatment of osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer*s disease |
| 04/22/2004 | US20040077698 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors |
| 04/22/2004 | US20040077696 Heterocyclic inhibitors of kinases |
| 04/22/2004 | US20040077695 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 04/22/2004 | US20040077687 Thiazolmines and their use as tgf-beta inhibitors |
| 04/22/2004 | US20040077686 Inhibition of cyclooxygenase-2 activity |
| 04/22/2004 | US20040077685 Analogs of thalidomide as potential angiogenesis inhibitors |
| 04/22/2004 | US20040077684 Piperidinyl compounds that selectively bind integrins |
| 04/22/2004 | US20040077681 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 04/22/2004 | US20040077678 Urea substituted imidazoquinoline ethers |
| 04/22/2004 | US20040077675 Compounds and methods for inhibiting MRP1 |
| 04/22/2004 | US20040077674 Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs |
| 04/22/2004 | US20040077672 Anticarcinogenic, antiproliferative, and antitumor agents |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | US20040077668 Compounds, compositins, and methods |
| 04/22/2004 | US20040077667 Quinazolinone derivatives |
| 04/22/2004 | US20040077666 Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents |
| 04/22/2004 | US20040077664 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 04/22/2004 | US20040077663 Thienopyrimidine-based inhibitors of the src family |
| 04/22/2004 | US20040077661 Treatment of tuberous sclerosis associated neoplasms |
| 04/22/2004 | US20040077651 Fused N-heterocycle compounds as type-X sPLA2 (secretary PLA2) inhibitors; anticarcinogenic agents |
| 04/22/2004 | US20040077649 Novel cannabimimetic ligands |
| 04/22/2004 | US20040077648 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 04/22/2004 | US20040077632 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/22/2004 | US20040077629 Such as 4-methyl-2-hydroxy-2-(4-hydroxy-4-methylpentyl)-butanediocate ester cephalotaxine derivative |
| 04/22/2004 | US20040077612 Acting as prodrugs; higher concentration delivery of active material to target cell in hybrid form; decreasing side effects |
| 04/22/2004 | US20040077610 Medicament containing a polyamine as an active substance |
| 04/22/2004 | US20040077598 Copolymer containing aminofunctionalized alkoxysiloxane monomer; slowing abnormal cell growth and proliferation while increasing death rate |